Unknown

Dataset Information

0

Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells.

ABSTRACT: The mechanisms of estrogen insensitivity or estrogen resistance in ovarian cancer cells are not known. Studies on regulation of the estrogen receptor (ER) gene have suggested a role for epigenetics in silencing ER expression.Cells from insensitive ovarian cancer cells, SKOV3 and HEY, were cultured with and without the DNA methyltransferase (DNMT) inhibitor, 5-aza-2'-deoxycytidine (AzaC) and the histone deacetylase (HDAC) inhibitor, trichostatin (TSA). ERbeta promoter methylation was examined using bisulfite sequencing. RNA was collected for oligonucleotide array studies.Cell type-specific ERbeta promoter methylation was found as well as relative hypomethylation of the ERbeta promoter in SKOV3 compared to HEY cells. Preferential demethylation of specific CpGs by different treatments was found. AzaC and TSA resulted in significant tumor growth inhibition and alterations in expression of numerous genes.The ERbeta promoter is differentially methylated in ovarian cancer cells. Moreover, AzaC and TSA can inhibit ovarian cancer cell growth.

SUBMITTER: Yap OW 

PROVIDER: S-EPMC2737468 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells.

Yap Oi Wah Stephanie OW   Bhat Ganapathy G   Liu Liang L   Tollefsbol Trygve O TO  

Anticancer research 20090101 1

<h4>Background</h4>The mechanisms of estrogen insensitivity or estrogen resistance in ovarian cancer cells are not known. Studies on regulation of the estrogen receptor (ER) gene have suggested a role for epigenetics in silencing ER expression.<h4>Materials and methods</h4>Cells from insensitive ovarian cancer cells, SKOV3 and HEY, were cultured with and without the DNA methyltransferase (DNMT) inhibitor, 5-aza-2'-deoxycytidine (AzaC) and the histone deacetylase (HDAC) inhibitor, trichostatin (T  ...[more]

Similar Datasets

Unknown Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer.
| S-EPMC3435304 | biostudies-literature
Unknown Calcitriol induces estrogen receptor α expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cells.
| S-EPMC8727803 | biostudies-literature
Unknown Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.
| S-EPMC9266546 | biostudies-literature
Unknown Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.
| S-EPMC2663411 | biostudies-literature
Unknown Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
| S-EPMC5564823 | biostudies-literature
Unknown Estrogen Receptor-β Expression of Ovarian Tumors and Its Association with Ovarian Cancer Risk Factors.
| S-EPMC7641961 | biostudies-literature
Unknown Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells.
| S-EPMC3982489 | biostudies-literature
Transcriptomics Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist
2022-07-13 | GSE197320 | GEO
Unknown Indole Derivative Interacts with Estrogen Receptor Beta and Inhibits Human Ovarian Cancer Cell Growth.
| S-EPMC7582771 | biostudies-literature
Unknown Haplotypes of the estrogen receptor beta gene and breast cancer risk.
| S-EPMC2796078 | biostudies-literature